๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pediatric nonalcoholic steatohepatitis associated with hypopituitarism

โœ Scribed by Kenichirou Nakajima; Etsuko Hashimoto; Hiroyuki Kaneda; Katsutoshi Tokushige; Keiko Shiratori; Naomi Hizuka; Kazue Takano


Book ID
106179677
Publisher
Springer Japan
Year
2005
Tongue
English
Weight
339 KB
Volume
40
Category
Article
ISSN
0944-1174

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Orlistat for overweight subjects with no
โœ Joanna K. Dowman; Deborah Stocken; Jeremy W. Tomlinson; Philip Newsome ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 47 KB ๐Ÿ‘ 1 views

We read with interest the article by Harrison et al. 1 on the use of Orlistat in overweight patients with nonalcoholic steatohepatitis (NASH). Their prospective randomized trial of 41 patients concluded that improvement in liver histology was not significantly different after 36 weeks of treatment w

Orlistat for overweight subjects with no
โœ Teoman Dogru; Cemal Nuri Ercin; Ilker Tasci; Serkan Tapan; Zeki Yesilova; Ahmet ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 41 KB ๐Ÿ‘ 1 views

We read with great interest the article by Harrison et al. reporting the effect of Orlistat, an inhibitor of fat absorption, on the metabolic abnormalities, histopathologic findings, and cytokine levels in subjects with nonalcoholic steatohepatitis (NASH). 1 They showed that when compared to control